Antares Pharma, Inc. (ATRS)

[ou71764]

Good points. I am optimistic about Apple's presentation, but I agree that the burden of proof is on the company. I am not expecting a huge move tomorrow, but I think we will end higher and never be this low again.

Obviously anything can happen tomorrow and the rest of the year. But a company with multiple approved revenue streams is totally different that a biotech trying to get their first approved therapy. I particularly like that Pfizer approached us for a partnership.

I am very long.